BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15246322)

  • 1. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
    Das A; Dasgupta A; Sengupta T; Majumder HK
    Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerases of kinetoplastid parasites: why so fascinating?
    Das BB; Sengupta T; Ganguly A; Majumder HK
    Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy.
    Das BB; Ganguly A; Majumder HK
    Adv Exp Med Biol; 2008; 625():103-15. PubMed ID: 18365662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics.
    Das BB; Sen N; Dasgupta SB; Ganguly A; Das R; Majumder HK
    Indian J Med Res; 2006 Mar; 123(3):221-32. PubMed ID: 16778306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting atypical trypanosomatid DNA topoisomerase I.
    Balaña-Fouce R; Redondo CM; Pérez-Pertejo Y; Díaz-González R; Reguera RM
    Drug Discov Today; 2006 Aug; 11(15-16):733-40. PubMed ID: 16846801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases.
    Shakur Y; de Koning HP; Ke H; Kambayashi J; Seebeck T
    Handb Exp Pharmacol; 2011; (204):487-510. PubMed ID: 21695653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Topoisomerases of Kinetoplastid Parasites: Brief Overview and Recent Perspectives.
    Saha S; Chowdhury SR; Majumder HK
    Curr Issues Mol Biol; 2019; 31():45-62. PubMed ID: 31165719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
    Navarro M; Gabbiani C; Messori L; Gambino D
    Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerases in life and death: implications in kinetoplastid protozoa.
    Chowdhury AR; Majumder HK
    Curr Mol Med; 2004 Sep; 4(6):711-22. PubMed ID: 15357219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetoplastid papain-like cysteine peptidases.
    Caffrey CR; Steverding D
    Mol Biochem Parasitol; 2009 Sep; 167(1):12-9. PubMed ID: 19409421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetoplast as a potential chemotherapeutic target of trypanosomatids.
    Motta MC
    Curr Pharm Des; 2008; 14(9):847-54. PubMed ID: 18473834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
    Hammarton TC; Mottram JC; Doerig C
    Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapeutic effectiveness of stibomen in experimental leishmaniasis and trypanosomiasis].
    Pershin GN; Moskalenko NIu
    Med Parazitol (Mosk); 1967; 36(4):422-7. PubMed ID: 5612807
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy of trypanosomiases and leishmaniasis.
    Croft SL; Barrett MP; Urbina JA
    Trends Parasitol; 2005 Nov; 21(11):508-12. PubMed ID: 16150644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerases in the unicellular protozoan parasites: Unwinding the mystery.
    Lamba S; Roy A
    Biochem Pharmacol; 2022 Sep; 203():115158. PubMed ID: 35780829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerases as targets for antiprotozoal therapy.
    Bakshi RP; Shapiro TA
    Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution and diversity of kinetoplastid flagellates.
    Simpson AG; Stevens JR; Lukes J
    Trends Parasitol; 2006 Apr; 22(4):168-74. PubMed ID: 16504583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal complexes as chemotherapeutic agents against tropical diseases: malaria, trypanosomiasis, and leishmaniasis.
    Sánchez-Delgado RA; Anzellotti A; Suárez L
    Met Ions Biol Syst; 2004; 41():379-419. PubMed ID: 15206123
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA Topoisomerases of Leishmania Parasites; Druggable Targets for Drug Discovery.
    Reguera RM; Elmahallawy EK; García-Estrada C; Carbajo-Andrés R; Balaña-Fouce R
    Curr Med Chem; 2019; 26(32):5900-5923. PubMed ID: 29773051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.